The Society of Gynecologic Oncologists (SGO) will host its 41st Annual Meeting on Women's Cancer March 14-17, 2010 at the Moscone West Convention Center in San Francisco, California. This year's meeting will feature more than 434 scientific presentations in addition to lectures, workshops, symposia and postgraduate courses that focus on emerging science, clinical trials and treatment advances for physicians and health care professionals in the field of gynecologic oncology. This year's meeting attracted 839 research and clinical trial abstracts submitted from all over the world — the most submitted since the Annual Meeting's inception in 1969.
The comprehensive, broad range of educational programming offered at the Annual Meeting mirrors the core competencies of gynecologic oncologists -- surgical disease management, medical/oncologic/radio-therapeutic treatment, preventative medicine and scientific research. The meeting traditionally attracts medical oncologists, radiation oncologists, obstetrician/gynecologists, oncology nurses and allied health professionals who comprise the medical care team treating women with gynecologic malignancies.
"Attendees will be extremely pleased with the educational programming we've put together for our 41st Annual Meeting," says SGO President, David G. Mutch, M.D. "Our program committee has added an array of new sessions, including our Seminal Abstract Session that directly speaks to our ongoing efforts to elevate the level of science presented each year."
For four decades, gynecologic oncologists have been dedicated to the care and treatment of women's cancers including ovarian, cervical, endometrial, vulvar and vaginal cancer. Gynecologic oncologists have also been leaders in conducting research and clinical trials to improve patient care standards, treatment methods, and preventative and diagnostic medicine.
As the preeminent society for these physicians, the SGO hosts its Annual Meeting to not only offer educational opportunities, but to also spotlight the newest, emerging research focused on identifying and ultimately eradicating these life-threatening diseases.
"As the Society's premier educational event, we believe that the science presented and the exchange of ideas will impact future research studies and positively affect the subspecialty of gynecologic oncology," says Dr. Mutch. "The information shared during this meeting is the basis for refined surgical techniques, additional clinical trials and multiple teaching opportunities within institutions and private practice settings alike. It is our sincere hope the Annual Meeting will offer a renewed sense of inspiration and commitment toward our goal of improving cancer prevention and treatment for women across the world."
AI models redefine TIL scoring in breast cancer but face challenges in real-world validation